Muses Labs to Showcase Precision Medicine Technology for Complex Diseases
RALEIGH, N.C. August 26, 2016 – Muses Labs announced today it has been selected as a Showcase Company to present on the Main Stage at this year’s CED Tech Venture Conference to be held September 13th and 14th at the Raleigh Convention Center.
CED describes the Tech Venture Conference as follows:
“As the premier event for technology entrepreneurs in the Southeast, the CED Tech Venture Conference attracts some of the most innovative minds from across the nation to Raleigh, NC, recently ranked the #5 tech hotspot. From early startups to growth-stage companies to highly successful businesses, the CED Tech Venture Conference reflects North Carolina’s vibrant entrepreneurial community and showcases many of the most promising emerging companies in the region.”
Muses Labs will showcase its initial solution targeting age-related cognitive decline and the spectrum of Alzheimer’s disease. The company has developed a data-driven, technology-enabled solution to help physicians correctly identify and simultaneously treat the dozens of underlying causes of age-related cognitive decline. The solution targets people who are beginning to have symptoms of age-related cognitive decline and those with a family history of dementia. Proprietary algorithms within the solution recommend optimal medical interventions personalized for each person with a goal of improving memory and cognitive function.
Muses Labs’ CTO, John Q. Walker, recently presented pilot results at the Alzheimer’s Association International Conference (AAIC). Early data show Muses Labs’ solutions have the potential to improve memory and cognitive function in greater than 50% of individuals that followed their personalized plan for at least six months.
Beyond Alzheimer’s, Muses Labs’ solutions will expand to cover additional complex and chronic diseases such as Parkinson’s, autism, Chronic Fatigue Syndrome and diabetes, among others. Additional studies are planned in collaboration with leading research centers and other health technology partners.
About Muses Labs
Muses Labs brings together 30 years of scientific research, hundreds of published clinical studies, and a team of highly respected Alzheimer’s researchers, doctors and advanced technology. The company applies its clinical precision medicine platform and technology-enabled protocol to collect individual patient medical and behavioral data, identify underlying causes of age-related cognitive decline (such as Alzheimer’s disease and memory loss) and design personalized treatment plans. A comprehensive adherence program supports individuals and their caregivers to improve patient outcomes. For more information, visit www.museslabs.com.
Crossroads B2B Consulting